About Neuronetics
Neuronetics is a company based in Malvern (United States) founded in 2001.. Neuronetics has raised $177.8 million across 8 funding rounds from investors including General Electric, New Leaf Venture Partners and Ascension Ventures. The company has 167 employees as of December 31, 2022. Neuronetics offers products and services including NeuroStar Advanced Therapy System. Neuronetics operates in a competitive market with competitors including Muse, Flow Neuroscience, Freespira, Sooma Oy and HypnoVR, among others.
- Headquarter Malvern, United States
- Employees 167 as on 31 Dec, 2022
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neuronetics, Inc.
-
Annual Revenue
$15.27 M2327as on Dec 31, 2024
-
Net Profit
$-19 K100as on Dec 31, 2024
-
EBITDA
$-34.56 M-13as on Dec 31, 2024
-
Total Equity Funding
$177.8 M (USD)
in 8 rounds
-
Latest Funding Round
$15 M (USD), Series G
Jun 06, 2017
-
Investors
General Electric
& 14 more
-
Employee Count
167
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neuronetics
Neuronetics offers a comprehensive portfolio of products and services, including NeuroStar Advanced Therapy System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive TMS treatment for depression and comorbid anxiety symptoms.
Funding Insights of Neuronetics
Neuronetics has successfully raised a total of $177.8M across 8 strategic funding rounds. The most recent funding activity was a Series G round of $15 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series G — $15.0M
- First Round First Round
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Series G - Neuronetics | Valuation |
investors |
|
| Apr, 2015 | Amount | Series F - Neuronetics | Valuation |
investors |
|
| May, 2011 | Amount | Series E - Neuronetics | Valuation | Polaris Partners , Pfizer Venture Investments |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neuronetics
Neuronetics has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include General Electric, New Leaf Venture Partners and Ascension Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Strategic investments in healthcare technologies and data innovations.
|
Founded Year | Domain | Location | |
|
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
|
Founded Year | Domain | Location | |
|
Early-stage investing in IT and healthcare ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neuronetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neuronetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neuronetics Comparisons
Competitors of Neuronetics
Neuronetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Muse, Flow Neuroscience, Freespira, Sooma Oy and HypnoVR, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
EEG-powered headbands for meditation and sleep biofeedback are developed.
|
|
| domain | founded_year | HQ Location |
Provider of a wearable device for stress and anxiety management
|
|
| domain | founded_year | HQ Location |
Panic disorders are treated via breathing device and mobile app.
|
|
| domain | founded_year | HQ Location |
Non-invasive neuromodulation therapies
|
|
| domain | founded_year | HQ Location |
Virtual reality therapies for pain and anxiety reduction are developed.
|
|
| domain | founded_year | HQ Location |
Provider of digital Precision Medicine company leveraging objective data and passive measurement for mental healthcare
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neuronetics
Frequently Asked Questions about Neuronetics
When was Neuronetics founded?
Neuronetics was founded in 2001.
Where is Neuronetics located?
Neuronetics is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
Is Neuronetics a funded company?
Neuronetics is a funded company, having raised a total of $177.8M across 8 funding rounds to date. The company's 1st funding round was a Series E of $30M, raised on Aug 22, 2001.
How many employees does Neuronetics have?
As of Dec 31, 2022, the latest employee count at Neuronetics is 167.
What is the annual revenue of Neuronetics?
Annual revenue of Neuronetics is $15.27M as on Dec 31, 2024.
What does Neuronetics do?
Neuronetics, Inc. was founded in 2001 by The Innovation Factory in Atlanta and is headquartered in Malvern, United States. Non-invasive therapies for psychiatric and neurological disorders are developed using MRI-strength magnetic field pulses. A depression treatment, non-systemic and non-invasive, has been cleared by the FDA for patients unresponsive to prior antidepressants. Operations center on medical device innovation within the healthcare sector, targeting unmet needs in mental health.
Who are the top competitors of Neuronetics?
Neuronetics's top competitors include Muse, Flow Neuroscience and Freespira.
What products or services does Neuronetics offer?
Neuronetics offers NeuroStar Advanced Therapy System.
Who are Neuronetics's investors?
Neuronetics has 15 investors. Key investors include General Electric, New Leaf Venture Partners, Ascension Ventures, Accuitive Medical Ventures, and InterWest.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.